Delivery Order SPE2DB22D3004-SPE2DB25FSE17
- Not listed
- The Defense Logistics Agency awarded a $3,425.95 delivery order to AmerisourceBergen Drug Corp for Esbriet 801 mg tablets (90-count supply) on July 7, 2025, with an ultimate completion date of July 28, 2025. This is a competitively awarded, firm fixed-price contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,425.95 for Esbriet (pirfenidone) 801 mg tablets, a quantity of 90 units, with an ultimate completion date of September 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves...
- The Defense Logistics Agency awarded a $3,425.95 delivery order to AmerisourceBergen Drug Corp on May 14, 2025, for the supply of Esbriet (pirfenidone) 801 mg tablets in a 90-count package. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of June 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this contract at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Esbriet 801 mg tablets (90-count units) with a contract ceiling value of $3,425.95. This non-set-aside, competitively awarded delivery order carries firm fixed pricing and is scheduled for completion by June 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,425.95 to AmerisourceBergen Drug Corp for 90 tablets of Esbriet 801 mg, a pharmaceutical product for pulmonary fibrosis treatment. This non-competitive, firm fixed-price delivery order was awarded on June 12, 2025, with an ultimate completion date of July 7, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical supply...
- The Defense Logistics Agency awarded a $3,425.95 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Esbriet (pirfenidone) 267 mg tablets in a quantity of 270 units. This non-set-aside, competitively awarded contract carries a firm fixed price structure with an ultimate completion date of October 8, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a competitive, firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Esbriet 267 mg tablets (270 count) with a ceiling value of $6,851.90 and completion deadline of November 6, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency issued a delivery order on June 16, 2025, to AmerisourceBergen Drug Corp for the supply of Esbriet (pirfenidone) 267 mg tablets in a quantity of 270 tablets, with a ceiling value of $3,425.95. This order is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 9, 2025....
- The Defense Logistics Agency awarded a $3,425.95 delivery order to AmerisourceBergen Drug Corp for 270 tablets of Esbriet 267 mg on July 30, 2025, with an ultimate completion date of August 20, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain for 270 tablets of Esbriet 267 mg on September 23, 2025, with a ceiling value of $6,851.90 and an ultimate completion date of October 15, 2025. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FSE17Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,425.95 to AmerisourceBergen Drug Corp for the supply of Esbriet (pirfenidone) 801 mg tablets in a quantity of 90 units. This non-competitive, firm fixed-price delivery order is scheduled for completion by September 17, 2025, with performance at AmerisourceBergen's corporate office facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under the company's existing contract vehicle with the DLA Medical Supply Chain. This delivery order is executed under AmerisourceBergen's broader $999.99 billion Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. As a major pharmaceutical distributor, AmerisourceBergen supplies a wide range of medical products including specialty medications, brand-name and generic drugs, and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The current delivery order for Esbriet, a specialty antifibrotic medication used in pulmonary disease treatment, exemplifies the company's role in fulfilling specialized pharmaceutical needs within the military healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 8/26/25 |